Results 131 to 140 of about 1,288 (185)

Studying Candida Biofilms Across Species: Experimental Models, Structural Diversity, and Clinical Implications. [PDF]

Pharmaceuticals (Basel)
Squitieri D, Rizzo S, Torelli R, Mariotti M, Sanguinetti M, Cacaci M, Bugli F.   +6 more
europepmc   +1 more source

Past, present and future of antifungals: Advancements in mechanisms of action and resistance. [PDF]

Curr Res Microb Sci
Santos ALS, Rodrigues CF, Roudbary M, Branquinha MH.   +3 more
europepmc   +1 more source

SCY-247, a novel second-generation triterpenoid antifungal, demonstrates high in vitro activity against genetically diverse Candida auris isolates, including FKS1 mutants. [PDF]

J Antimicrob Chemother
Spruijtenburg B, de Groot T, Meijer EFJ.
europepmc   +1 more source

Safety, tolerability, and pharmacokinetics of ibrexafungerp in healthy Chinese subjects: a randomized, double-blind, placebo-controlled phase 1 trial. [PDF]

Antimicrob Agents Chemother, 2023
Liu X, Zhang R, Li R, Wu Q, Pan C, Yu X, Liu Y, Wang B, Yu S.   +8 more
europepmc   +1 more source

<i>In vitro</i> activity of novel antifungals, natamycin, and terbinafine against <i>Fusarium</i>. [PDF]

Antimicrob Agents Chemother
Garbe E, Ullah A, Aldejohann AM, Kurzai O, Janevska S, Walther G.   +5 more
europepmc   +1 more source

Identification and antifungal susceptibility patterns of reference yeast strains to novel and conventional agents: a comparative study using CLSI, EUCAST and Sensititre YeastOne methods. [PDF]

JAC Antimicrob Resist
Ceballos-Garzon A, Holzapfel M, Welsch J, Mercer D.   +3 more
europepmc   +1 more source

Genomic Insights of <i>Candida krusei</i>, an Emerging Fungal Pathogen With Intrinsic Antifungal Resistance. [PDF]

Open Forum Infect Dis
Jain K, Wadhwa K, Malik M, Haque S, Prieto MA, Kaur H.   +5 more
europepmc   +1 more source

Microbe Profile: <i>Candidozyma auris:</i> an emergent and resilient yeast and new antifungal strategies. [PDF]

Microbiology (Reading)
Ramage G, Sherry L, Kean R.
europepmc   +1 more source

Faculty Opinions recommendation of The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2021
openaire   +2 more sources

First report of <i>Candida</i> (<i>Candidozyma) auris</i> infections in a human and a dolphin from the Dominican Republic: A One health perspective. [PDF]

Med Mycol Case Rep
Ferrara GA, Spruijtenburg B, Meijer EFJ, Meis JF, Ceballos-Garzon A, Caceres DH.   +5 more
europepmc   +1 more source